Genprex Inc

GNPX

Latest QuantConomy context for GNPX: asset profile, market coverage, scored signals, and source-linked SEC insider filings when available.

Asset class

stock

Primary venue

NASDAQ

Recent signals

SEC filings

Asset profile

QuantConomy has a structured record for GNPX. More descriptive asset metadata will appear here when the platform record includes it.

Latest signal rows

Recent signals for GNPX

Scored rows are pulled from the same signal API used by the digests.

Signal	Direction	Score	Observed	Reason
fundamental net income change	very bullish	76	May 13, 12:00 AM	GNPX (Q1 2026, net income): grew 72.5% (-$16.23M → -$4.46M). [sequential period basis, very bullish signal]
fundamental operating income change	very bullish	76	May 13, 12:00 AM	GNPX (Q1 2026, operating income): grew 71.0% (-$15.52M → -$4.49M). [sequential period basis, very bullish signal]
corporate event other event	neutral	70	Jun 22, 01:05 PM	GNPX filed 8-K: Other Events - 1 material event - [strong neutral signal]

FUNDAMENTAL signals are experimental: the generator was recently enabled and coverage is still being validated.

Market	Exchange	Source	Asset record
GNPX	NASDAQ	alphavantage	Genprex Inc
GNPX	NASDAQ	fmp	Genprex, Inc.
GNPX	NASDAQ	alpaca	Genprex, Inc. Common Stock

Buys, last 90d

Sells, last 90d

Rows

Date	Insider	Role	Type	Shares	Price	Value	Filing
Apr 14, 2026	LONGNECKER BRENT M	Insider	sale	8	$1.23	$10	4 on EDGAR
Dec 22, 2025	LONGNECKER BRENT M	Insider	grant	9,000	$0.00	$0	4 on EDGAR
Dec 22, 2025	Berger Mark Stanley	Chief Medical Officer	grant	28,500	$0.00	$0	4 on EDGAR
Dec 22, 2025	Confer Ryan M.	President, CEO and CFO	grant	45,000	$0.00	$0	4 on EDGAR
Dec 22, 2025	Moreno Toscano Jose Antonio	Insider	grant	9,000	$0.00	$0	4 on EDGAR
Dec 22, 2025	Wilson William R Jr.	Insider	grant	9,000	$0.00	$0	4 on EDGAR

Source: SEC filings via QuantConomy. Not investment advice.

Get the data

These rows come from the QuantConomy signal, asset, market, and SEC filings API surfaces, also available to AI agents over MCP.